欧洲多发性硬化症研究与治疗委员会(ECTRIMS)年会

官方网站：http://www.congrex.ch/ectrims2012.html

Guidelines for preparation of abstracts

1. Abstracts may only be submitted online. Abstracts submitted by fax or email will not be accepted.
2. Abstracts must be submitted in English. Please use UK English spelling.
3. The presenting author of an accepted abstract must register and attend the congress.
4. Poster presenters must be present and stand by their posters during their assigned poster sessions
5. Abstracts should contain only original material not published or presented elsewhere prior to 10 October 2012.
6. Use a short specific title indicating the nature of the investigation. The background and goals of the study should appear clearly to the reader. The methods and results must contain data, and the conclusions should be clearly expressed.
7. All abbreviations must be defined the first time they appear in your text (but, do not define in the title). Example: Multiple Sclerosis Impact Scale (MSIS), before being used as an abbreviation only.
8. Avoid complex mathematical formulae. For the symbols ≤ or ≥, type instead <= or >=. For superscript use caret (^) e.g. 10^6 instead of 106. Do not use Greek letters and symbols. Instead of “IFN-γ” use for example “IFN-g” or “IFN-gamma”.
9. Use generic drug names.
10. Tables, charts or other graphics may not be included and will be deleted by the editors.
11. The abstract text may not be longer than 2500 characters including spaces (ca. 500 words).
12.  Authors should indicate their presentation preference:
    
    • poster presentation only
    • oral or poster presentation
    "Poster only" implies that your abstract will be considered for poster presentation only and will not be eligible for the poster prize (see corresponding paragraph).
    The Programme Committee reserves the right to decide on the final allocation and presentation method.
13. A selected number of abstracts will be accepted for oral presentation based on their scientific merits and on their relation to the topics addressed in the scientific programme of the Congress. We therefore encourage submissions on the main topics covered in the scientific programme.
14. Disclosure of conflict of interest (e.g. grant support, consultancy, membership on advisory councils, speaker’s bureau) and source of funding is mandatory. Each listed author should prepare a one sentence statement to this effect.
15. Please make sure to state your correct e-mail address. After having submitted your abstract, you will receive a confirmation by e-mail with the following information:
    
    • reference number of your abstract (for correspondence and questions that might arise)
    • your personal user code and password.
      (if you do not receive a confirmation by e-mail please contact the Abstract hotline!)
16. Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal access codes. This will shorten the submission procedure. Corrections to abstracts can only be made up to the deadline of 23 May 2012.

会议时间:2012/10/10--2012/10/13  地点:法国里昂